Pharmaceutical Composition With Synergistic Anticonvulsant Effect

Patent No. EP2037965 (titled "Pharmaceutical Composition With Synergistic Anticonvulsant Effect") was filed by Schwarz Pharma on Jun 15, 2007. The application was issued on Aug 30, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
ACCORD HEALTHCARE	May 30, 2018	TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 20, 2019
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Dec 20, 2019
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Dec 17, 2019
Termination of the opposition proceedings with revocation of patent
Nov 25, 2019
Advice of delivery
Sep 12, 2019
Advice of delivery
Sep 9, 2019
Advice of delivery
Sep 6, 2019
Advice of delivery
Sep 5, 2019
Acknowledgement of a document
Sep 5, 2019
Acknowledgement of a document
Sep 5, 2019
Decision revoking the European patent
Sep 5, 2019
Decision revoking the European patent
Sep 5, 2019
Notification concerning the date of oral proceedings
Sep 5, 2019
Notification concerning the date of oral proceedings
Sep 2, 2019
(Electronic) Receipt
Sep 2, 2019
Brief communication - Opposition proceedings
Sep 2, 2019
Letter accompanying subsequently filed items
Sep 2, 2019
Request for revocation of patent
Aug 30, 2019
Brief communication - Opposition proceedings
Aug 28, 2019
Consolidated list of cited opposition documents
Aug 27, 2019
(Electronic) Receipt
Aug 27, 2019
Brief communication - Opposition proceedings
Aug 27, 2019
Citation in opposition procedure - 013
Aug 27, 2019
Letter accompanying subsequently filed items
Aug 27, 2019
Written submission in preparation to/during oral proceedings
Aug 5, 2019
Brief communication - Opposition proceedings
Jul 26, 2019
(Electronic) Receipt
Jul 26, 2019
Letter accompanying subsequently filed items
Jul 26, 2019
Written submission in preparation to/during oral proceedings
Jul 24, 2019
Brief communication - Opposition proceedings
Jul 18, 2019
(Electronic) Receipt
Jul 18, 2019
Letter accompanying subsequently filed items
Jul 18, 2019
Request for interpreters during oral proceedings
Jan 9, 2019
Advice of delivery
Jan 9, 2019
Advice of delivery
Jan 8, 2019
Advice of delivery
Jan 7, 2019
Advice of delivery
Jan 4, 2019
Acknowledgement of a document
Jan 4, 2019
Acknowledgement of a document
Jan 4, 2019
Annex to the communication - opposition
Jan 4, 2019
Information concerning oral proceedings
Jan 4, 2019
Summons to attend oral proceedings
Jan 4, 2019
Summons to attend oral proceedings
Oct 29, 2018
Brief communication - Opposition proceedings
Oct 24, 2018
(Electronic) Receipt
Oct 24, 2018
Amended claims with annotations
Oct 24, 2018
Citation in opposition procedure - 007
Oct 24, 2018
Citation in opposition procedure - 008
Oct 24, 2018
Citation in opposition procedure - 009
Oct 24, 2018
Citation in opposition procedure - 010
Oct 24, 2018
Citation in opposition procedure - 011
Oct 24, 2018
Citation in opposition procedure - 012
Oct 24, 2018
Claims
Oct 24, 2018
Letter accompanying subsequently filed items
Oct 24, 2018
Reply of the patent proprietor to the notice(s) of opposition
Aug 31, 2018
Brief communication - Opposition proceedings
Aug 31, 2018
Communication of amended entries concerning the representative
Aug 28, 2018
(Electronic) Receipt
Aug 28, 2018
Authorisation
Aug 28, 2018
Letter accompanying subsequently filed items
Aug 28, 2018
Submission concerning change of applicant's representative
Jun 14, 2018
Communication of a notice of opposition and request to file observations
Jun 14, 2018
Notice of further oppositions to opponent(s)
Jun 7, 2018
Communication of a notice of opposition - first information to patent proprietor
May 30, 2018
(Electronic) Receipt
May 30, 2018
Citation in opposition procedure - 001
May 30, 2018
Citation in opposition procedure - 002
May 30, 2018
Citation in opposition procedure - 003
May 30, 2018
Citation in opposition procedure - 004
May 30, 2018
Citation in opposition procedure - 005
May 30, 2018
Citation in opposition procedure - 006
May 30, 2018
Notice of opposition
May 30, 2018
Notice of opposition
Aug 31, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Aug 3, 2017
Decision to grant a European patent
Jul 18, 2017
(Electronic) Receipt
Jul 18, 2017
Filing of the translations of the claims
Jul 18, 2017
French translation of claims
Jul 18, 2017
German translation of the claims
Jul 18, 2017
Letter accompanying subsequently filed items
May 12, 2017
Bibliographic data of the European patent application
May 12, 2017
Communication about intention to grant a European patent
May 12, 2017
Intention to grant (signatures)
May 12, 2017
Intention to grant (signatures)
May 12, 2017
Text intended for grant
Sep 16, 2016
(Electronic) Receipt
Sep 16, 2016
Amended claims with annotations
Sep 16, 2016
Claims
Sep 16, 2016
Letter accompanying subsequently filed items
Sep 16, 2016
Reply to communication from the Examining Division
Jun 2, 2016
Annex to the communication
Jun 2, 2016
Communication from the Examining Division
Mar 8, 2016
Transmittal of third party observations to applicant
Feb 27, 2016
Non-patent literature filed by a third party
Feb 27, 2016
Observations by third parties
Dec 9, 2015
(Electronic) Receipt
Dec 9, 2015
Amended claims with annotations
Dec 9, 2015
Amended description with annotations
Dec 9, 2015
Claims
Dec 9, 2015
Description
Dec 9, 2015
Letter accompanying subsequently filed items
Dec 9, 2015
Reply to communication from the Examining Division
Aug 19, 2015
Annex to the communication
Aug 19, 2015
Communication from the Examining Division
Dec 20, 2013
Claims
Dec 20, 2013
Reply to communication from the Examining Division
Nov 15, 2013
Communication confirming withdrawal from representation
Nov 15, 2013
Communication of amended entries concerning the representative
Nov 15, 2013
Grant of extension of time limit (examination procedure)
Nov 5, 2013
Request for extension of time limit to communication from the Examining Division
Sep 25, 2013
Submission concerning change of applicant's representative
Sep 25, 2013
Submission concerning change of applicant's representative
Jul 15, 2013
Annex to the communication
Jul 15, 2013
Communication from the Examining Division
Jul 8, 2013
Examination started
Feb 15, 2010
Communication of the registration of a transfer or change of name and/or address
Feb 12, 2010
Submission concerning change of applicant's name
Feb 9, 2010
Submission concerning change of applicant's name
Feb 25, 2009
Notification on forthcoming publication of bibliographic data
Feb 9, 2009
Communication regarding possible amendment of claims/payment of claims fees
Jan 8, 2009
Copy of the international preliminary report on patentability
Dec 22, 2008
Amended claims filed after receipt of (European) search report
Dec 22, 2008
Amended description filed after receipt of (European) search report
Dec 22, 2008
Amendments received before examination
Dec 22, 2008
Request for entry into the European phase
Oct 24, 2008
Information on entry into European phase
Sep 10, 2008
Reminder for payment period (examination fee/designation fees)
Sep 4, 2008
Copy of the international search report
Sep 4, 2008
International publication of the international search report
Jan 10, 2008
Priority document (electronically transmitted)
Dec 21, 2007
Published international application - A2
Sep 18, 2007
Notification relating to declaration under Rule 4.17 PCT (copy for ISA/EP)
Jun 15, 2007
Abstract
Jun 15, 2007
Annex
Jun 15, 2007
Claims
Jun 15, 2007
Description
Jun 15, 2007
Drawings
Jun 15, 2007
Priority document (RO-procedure)
Dec 1, 2006
Priority document (RO-procedure)
Nov 14, 2006
Priority document (RO-procedure)
Oct 19, 2006
Priority document (RO-procedure)

EP2037965

SCHWARZ PHARMA

Application Number: EP07764676A
Filing Date: Jun 15, 2007
Status: Revoked; Dec 20, 2019
Publication Date: Aug 30, 2017
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Composition With Synergistic Anticonvulsant Effect

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2037965